BioXcel Therapeutics (BTAI) Shares Issued (2017 - 2026)

BioXcel Therapeutics' Shares Issued history runs 10 years deep, the most recent figure standing at $8.5 million for Q1 2026.

• In Q1 2026, Shares Issued fell 39.33% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $52.6 million (up 96.53% YoY), while the FY2025 annual figure was $58.1 million, up 46.5% from the prior year.
• Shares Issued was $8.5 million for Q1 2026 at BioXcel Therapeutics, up from $5.8 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $38.2 million in Q3 2025 to a low of $48000.0 in Q3 2022.
• Historically, Shares Issued has averaged $8.9 million across 5 years, with a median of $5.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Issued sank 99.95% in 2022, then surged 50210.42% in 2023.
• A 5-year view of Shares Issued shows it stood at $50000.0 in 2022, then jumped by 4650.0% to $2.4 million in 2023, then jumped by 194.78% to $7.0 million in 2024, then fell by 17.7% to $5.8 million in 2025, then surged by 47.48% to $8.5 million in 2026.
• The last three Shares Issued figures came in at $8.5 million (Q1 2026), $5.8 million (Q4 2025), and $38.2 million (Q3 2025), per Business Quant data.